BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 37574159)

  • 21.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
    Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H
    PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
    Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease.
    Koutarapu S; Ge J; Jha D; Blennow K; Zetterberg H; Lashley T; Michno W; Hanrieder J
    Brain Connect; 2023 Jun; 13(5):297-306. PubMed ID: 36074939
    [No Abstract]   [Full Text] [Related]  

  • 26. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
    Klementieva O; Willén K; Martinsson I; Israelsson B; Engdahl A; Cladera J; Uvdal P; Gouras GK
    Nat Commun; 2017 Mar; 8():14726. PubMed ID: 28287086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.
    Meadowcroft MD; Connor JR; Smith MB; Yang QX
    J Magn Reson Imaging; 2009 May; 29(5):997-1007. PubMed ID: 19388095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging.
    Connor DM; Benveniste H; Dilmanian FA; Kritzer MF; Miller LM; Zhong Z
    Neuroimage; 2009 Jul; 46(4):908-14. PubMed ID: 19303447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
    Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
    Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer's disease.
    Whitesell JD; Buckley AR; Knox JE; Kuan L; Graddis N; Pelos A; Mukora A; Wakeman W; Bohn P; Ho A; Hirokawa KE; Harris JA
    J Comp Neurol; 2019 Sep; 527(13):2122-2145. PubMed ID: 30311654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
    Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM
    PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
    Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
    Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues.
    Everett J; Brooks J; Tjendana Tjhin V; Lermyte F; Hands-Portman I; Plascencia-Villa G; Perry G; Sadler PJ; O'Connor PB; Collingwood JF; Telling ND
    ACS Chem Neurosci; 2024 Apr; 15(7):1469-1483. PubMed ID: 38501754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.